MASCI, DOMIZIANA
 Distribuzione geografica
Continente #
NA - Nord America 602
EU - Europa 539
AS - Asia 169
AF - Africa 13
SA - Sud America 10
Totale 1.333
Nazione #
US - Stati Uniti d'America 593
IT - Italia 400
SG - Singapore 87
SE - Svezia 34
IN - India 31
CN - Cina 27
FI - Finlandia 25
DE - Germania 17
TG - Togo 12
BG - Bulgaria 9
FR - Francia 8
CA - Canada 7
GB - Regno Unito 7
AR - Argentina 6
BE - Belgio 6
ID - Indonesia 6
BD - Bangladesh 5
HR - Croazia 5
UA - Ucraina 5
IE - Irlanda 4
IR - Iran 4
RO - Romania 4
RU - Federazione Russa 4
NL - Olanda 3
CL - Cile 2
HK - Hong Kong 2
LT - Lituania 2
MX - Messico 2
PK - Pakistan 2
PL - Polonia 2
TR - Turchia 2
BR - Brasile 1
CH - Svizzera 1
CZ - Repubblica Ceca 1
ES - Italia 1
IL - Israele 1
JP - Giappone 1
MY - Malesia 1
PE - Perù 1
PT - Portogallo 1
ZA - Sudafrica 1
Totale 1.333
Città #
Rome 234
Fairfield 81
Singapore 62
Ashburn 54
Chandler 47
Santa Clara 38
Seattle 31
Woodbridge 26
Wilmington 25
Princeton 24
Cambridge 23
Fasano 22
Helsinki 22
Ann Arbor 20
Houston 19
New York 18
Millbury 16
Fremont 13
Dearborn 12
Lomé 12
San Diego 12
Plano 11
Beijing 9
Florence 9
Sofia 9
Mannheim 7
Boardman 6
Brussels 6
Jakarta 6
Toronto 6
Washington 6
Cattolica 5
San Paolo di Civitate 5
Zagreb 5
Dublin 4
Lawrence 4
Milan 4
Norwalk 4
Redwood City 4
Bari 3
Bernal 3
Federal 3
Frankfurt am Main 3
Lappeenranta 3
Naples 3
Pontelandolfo 3
Rogliano 3
Aprilia 2
Bologna 2
Boston 2
Bremen 2
Cassano delle Murge 2
Dongguan 2
Ferentino 2
Frosinone 2
Hong Kong 2
Hyderabad 2
Kunming 2
Laurel 2
Los Angeles 2
Mexico City 2
Minturno 2
Monza 2
Nanjing 2
Padova 2
Philadelphia 2
Romainville 2
Salerno 2
San Mateo 2
Tianjin 2
Tübingen 2
Vercelli 2
Alatri 1
Andover 1
Ankara 1
Ardea 1
Bern 1
Busto Arsizio 1
Catania 1
Ceccano 1
Cerano 1
Cinisello Balsamo 1
Columbus 1
Des Moines 1
Falkenstein 1
Falls Church 1
Ferndale 1
Gentilly 1
Giarre 1
Gloucester 1
Holon 1
Istanbul 1
Jingmen 1
Kilburn 1
Las Vegas 1
Lima 1
Liscate 1
London 1
Modderfontein 1
Moscow 1
Totale 1.023
Nome #
Anticancer activity of (S)-5-Chloro-3-((3,5-dimethylphenyl)sulfonyl)-N-(1-oxo-1-((pyridin-4-ylmethyl)amino)propan-2-yl)-1H-indole-2-carboxamide (RS4690), a new dishevelled 1 inhibitor 121
Switching on the activity of 1,5-diaryl-pyrrole derivatives against drug-resistant ESKAPE bacteria: structure-activity relationships and mode of action studies 104
New 6- and 7-heterocyclyl-1H-indole derivatives as potent tubulin assembly and cancer cell growth inhibitors 101
Chiral indolylarylsulfone non-nucleoside reverse transcriptase inhibitors as new potent and broad spectrum anti-HIV-1 agents 97
Inhibition of dengue virus replication by novel inhibitors of RNA-dependent RNA polymerase and protease activities 91
New indolylarylsulfone non-nucleoside reverse transcriptase inhibitors show low nanomolar inhibition of single and double HIV-1 mutant strains 80
RS6077 induces mitotic arrest and selectively activates cell death in human cancer cell lines and in a lymphoma tumor in vivo 72
Induction of Ferroptosis in Glioblastoma and Ovarian Cancers by a New Pyrrole Tubulin Assembly Inhibitor 63
Small molecule inhibitors of kdm5 histone demethylases increase the radiosensitivity of breast cancer cells overexpressing JARID1B 61
Novel N-(Heterocyclylphenyl)benzensulfonamide Sharing an Unreported Binding Site with T-Cell Factor 4 at the β-Catenin Armadillo Repeats Domain as an Anticancer Agent 61
4-(3-Phenyl-4-(3,4,5-trimethoxybenzoyl)-1H-pyrrol-1-yl)benzenesulfonamide, a Novel Carbonic Anhydrase and Wnt/β-Catenin Signaling Pathway Dual-Targeting Inhibitor with Potent Activity against Multidrug Resistant Cancer Cells 54
Design, synthesis and biological evaluation of PDZ1 targeting NHERF1 inhibitors as anticancer agents 51
Biocatalytic aromatization of indolines into indoles by monoamine oxidase (MAO-N) whole cells 50
Targeting the Grb2 cSH3 domain: design, synthesis and biological evaluation of the first series of modulators 48
Drug design and synthesis of new indolylarylsulfones as HIV-1 non-nucleoside reverse transcriptase inhibitors 41
Drug design and synthesis of new indolylarylsulfones as HIV-1 non-nucleoside reverse transcriptase inhibitors 40
Indolylarylsulfones with potent anti-HIV-1 activity 36
Inhibition of Dengue virus by novel inhibitors of RNA-dependent RNA polymerase and protease activities 34
Drug design and synthesis of new indolylarylsulfones as HIV-1 non-nucleoside reverse transcriptase inhibitors 34
Indolylarylsulfones as novel potent anti-HIV-1 agents 34
Switching on the activity of 1,5-diaryl-pyrrole derivatives against drug-resistant ESKAPE bacteria 33
Metabolic Rewiring in Cancer: Small Molecule Inhibitors in Colorectal Cancer Therapy 25
null 25
Recent advances in drug discovery for Triple-Negative Breast cancer treatment 23
Emerging direct targeting β-catenin agents 18
Valorisation of Side Stream Products through Green Approaches: The Rapeseed Meal Case 17
A facile and regioselective multicomponent synthesis of chiral aryl-1,2-mercaptoamines in water followed by monoamine oxidase (MAO-N) enzymatic resolution 17
Targeting CBP and p300. Emerging anticancer agents 4
Totale 1.435
Categoria #
all - tutte 5.028
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.028


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202077 0 0 0 0 0 0 21 15 17 14 6 4
2020/2021129 5 4 26 6 5 17 4 4 10 17 8 23
2021/2022184 1 7 11 4 27 6 1 16 24 12 31 44
2022/2023265 50 30 18 20 30 19 11 21 34 13 12 7
2023/2024384 41 29 25 21 21 58 29 45 15 32 37 31
2024/2025221 26 22 30 42 45 56 0 0 0 0 0 0
Totale 1.435